Friday, February 24, 2017 8:59:27 AM
It does appear there is a large number of companies competing in this generic. I wonder if they will manufacture the drug themselves and keep a bigger piece of the pie?
it appears we have 20-40 competitors? FDA orange book has 80 entries divide by two you get 40. There could be some duplicates I haven't gone through the listings that don't list the specific manufacturer in the summary page.
Another Drug manufacturer web site has the following list so our partner is a company not on the list...orange book has a more comprehensive listing...teva is amongst the list...I wonder if Endo/Par has a product in the works?
Manufacturer: ACTAVIS LABS FL INC
Approval date: June 16, 2004
Strength(s): 500MG [AB1]
Manufacturer: ACTAVIS LABS FL INC
Approval date: April 12, 2005
Strength(s): 750MG [AB]
Manufacturer: AMNEAL PHARMS NY
Approval date: January 3, 2008
Strength(s): 500MG [AB1], 750MG [AB]
Manufacturer: APOTEX
Approval date: December 14, 2004
Strength(s): 500MG [AB1]
Manufacturer: APOTEX
Approval date: December 29, 2005
Strength(s): 750MG [AB]
Manufacturer: AUROBINDO PHARMA LTD
Approval date: July 20, 2012
Strength(s): 500MG [AB1], 750MG [AB]
Manufacturer: BARR
Approval date: October 14, 2004
Strength(s): 750MG [AB]
Manufacturer: BEXIMCO PHARMS USA
Approval date: December 13, 2016
Strength(s): 500MG [AB1], 750MG [AB]
Manufacturer: CSPC OUYI PHARM CO
Approval date: April 17, 2008
Strength(s): 500MG [AB1], 750MG [AB]
Manufacturer: INVENTIA HLTHCARE
Approval date: January 18, 2012
Strength(s): 500MG [AB1]
Manufacturer: MACLEODS PHARMS LTD
Approval date: December 7, 2016
Strength(s): 500MG [AB1], 750MG [AB]
Manufacturer: MARKSANS PHARMA
Approval date: April 29, 2016
Strength(s): 500MG [AB1], 750MG [AB]
Manufacturer: MYLAN
Approval date: September 8, 2005
Strength(s): 750MG [AB]
Manufacturer: MYLAN
Approval date: September 13, 2005
Strength(s): 500MG [AB1]
Manufacturer: NOSTRUM PHARMS LLC
Approval date: July 26, 2006
Strength(s): 500MG [AB1]
Manufacturer: NOSTRUM PHARMS LLC
Approval date: December 12, 2011
Strength(s): 750MG [AB]
Manufacturer: SANDOZ
Approval date: December 14, 2004
Strength(s): 500MG [AB1]
Manufacturer: SUN PHARM INDS (IN)
Approval date: February 9, 2006
Strength(s): 500MG [AB1], 750MG [AB]
Manufacturer: TEVA
Approval date: June 18, 2004
Strength(s): 500MG [AB1]
Manufacturer: TEVA
Approval date: April 12, 2005
Strength(s): 750MG [AB]
Manufacturer: TORRENT PHARM
Approval date: December 30, 2009
Strength(s): 500MG [AB1]
Manufacturer: ZYDUS PHARMS USA
Approval date: April 20, 2005
Strength(s): 500MG [AB1]
Manufacturer: ZYDUS PHARMS USA
Approval date: April 21, 2005
Strength(s): 750MG [AB]
Recent IPCI News
- Suspension de la négociation par l'Organisme canadien de réglementation des investissements - IPCI • PR Newswire (Canada) • 03/06/2024 12:55:00 PM
- Canadian Investment Regulatory Organization Trading Halt - IPCI • PR Newswire (Canada) • 03/06/2024 12:51:00 PM
- L'Organisme canadien de réglementation des investissements permet la reprise de la négociation - IPCI • PR Newswire (Canada) • 06/08/2023 05:30:00 PM
- Canadian Investment Regulatory Organization Trade Resumption - IPCI • PR Newswire (Canada) • 06/08/2023 05:28:00 PM
- Intellipharmaceutics Announces Fiscal Year 2022 and First Quarter 2023 Results • PR Newswire (Canada) • 06/06/2023 10:00:00 AM
ILUS Provides an Update on the Binding Term Sheet Signed with Actelis Networks (NASDAQ: ASNS) • ILUS • May 31, 2024 12:52 PM
Element79 Gold To Provide Summary and Update on Active Exploration Program, Community Relations at RMEC on June 4 • ELEM • May 30, 2024 1:18 PM
Branded Legacy Secures Exclusive Extraction Partnership with One of the World's Largest Kava Distributors and Producers • BLEG • May 30, 2024 8:30 AM
ECGI Holdings, Inc. Announces $2 Million Debt-to-Equity Conversion • ECGI • May 30, 2024 8:30 AM
North Bay Resources Reports Assays up to >25% Mg, 0.1% Ni, 0.1% Cu, 0.01% Co, 0.3 ppm Pt at Tulameen Platinum Project, British Columbia • NBRI • May 29, 2024 9:03 AM
One World Products, Inc. Issues Shareholder Update • OWPC • May 29, 2024 8:20 AM